tiprankstipranks
CDW Holding Limited (SG:BXE)
SGX:BXE
Want to see SG:BXE full AI Analyst Report?

CDW Holding (BXE) AI Stock Analysis

2 Followers

Top Page

SG:BXE

CDW Holding

(SGX:BXE)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
S$0.07
▼(-43.08% Downside)
Action:Reiterated
Date:07/31/26
The score is driven primarily by weak financial performance—multi-year revenue decline, margin compression, and ongoing losses—partly mitigated by moderate balance-sheet leverage and still-positive (but sharply declining) free cash flow. Technicals add downside pressure as the stock trades below all major moving averages. Valuation is mixed: a negative P/E reflects losses, while the very high dividend yield provides some support but also signals risk.
Positive Factors
Moderate Leverage
A low and improving debt-to-equity ratio (~0.19 in 2025) indicates manageable leverage and less refinancing pressure. That structural balance-sheet strength supports liquidity and financial flexibility, enabling the company to navigate cyclical weakness and fund operations or restructuring efforts.
Negative Factors
Multi-year Revenue Decline
A sustained and steep revenue decline (≈-20.9% in 2025) erodes scale and makes fixed-cost absorption harder. Reduced top-line size weakens competitive position, limits ability to invest in product or sales, and makes margin recovery and durable profitability more difficult without structural revenue stabilization.
Read all positive and negative factors
Positive Factors
Negative Factors
Moderate Leverage
A low and improving debt-to-equity ratio (~0.19 in 2025) indicates manageable leverage and less refinancing pressure. That structural balance-sheet strength supports liquidity and financial flexibility, enabling the company to navigate cyclical weakness and fund operations or restructuring efforts.
Read all positive factors

CDW Holding (BXE) vs. iShares MSCI Singapore ETF (EWS)

CDW Holding Business Overview & Revenue Model

Company Description
Established in 1991 and headquartered in Sha Tin, Hong Kong, CDW Holding Limited functions as an investment holding company with a global reach, including significant operations in Mainland China and Japan. The company primarily manufactures and d...
How the Company Makes Money
null...

CDW Holding Financial Statement Overview

Summary
Financial performance is weak overall: the income statement shows sharp multi-year revenue contraction, gross margin compression, and sustained net losses since 2023. The balance sheet is a partial offset with moderate leverage, and 2025 remained free-cash-flow positive, but cash generation fell sharply versus 2024, raising durability concerns.
Income Statement
24
Negative
Balance Sheet
62
Positive
Cash Flow
45
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue88.72M85.80M109.22M147.99M143.24M
Gross Profit12.31M13.55M18.72M25.68M26.11M
EBITDA-1.53M2.57M19.74M7.50M
Net Income-2.67M-4.42M-1.07M14.41M2.35M
Balance Sheet
Total Assets68.16M115.04M95.97M117.54M108.82M
Cash, Cash Equivalents and Short-Term Investments24.89M26.55M27.40M27.26M28.60M
Total Debt7.56M8.36M9.84M16.23M13.48M
Total Liabilities29.83M40.67M42.55M58.94M58.12M
Stockholders Equity39.89M44.90M54.66M59.50M50.69M
Cash Flow
Free Cash Flow1.46M4.71M9.54M4.10M2.50M
Operating Cash Flow2.48M5.34M10.95M4.96M3.78M
Investing Cash Flow-2.76M-433.00K526.00K-1.16M-2.60M
Financing Cash Flow-4.07M-5.54M-10.54M-1.42M-6.93M

CDW Holding Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.13
Price Trends
50DMA
0.08
Negative
100DMA
0.09
Negative
200DMA
0.11
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
47.56
Neutral
STOCH
59.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:BXE, the sentiment is Negative. The current price of 0.13 is above the 20-day moving average (MA) of 0.08, above the 50-day MA of 0.08, and above the 200-day MA of 0.11, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.56 is Neutral, neither overbought nor oversold. The STOCH value of 59.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:BXE.

CDW Holding Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
S$385.12M28.1726.70%2.24%11.38%22.41%
75
Outperform
S$427.60M21.217.94%4.05%-7.63%-33.33%
65
Neutral
S$2.24B44.3910.62%1.85%6.92%13.76%
64
Neutral
S$3.04B107.965.67%0.14%4.98%47.27%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
46
Neutral
S$17.76M-5.11-7.24%9.81%-0.46%43.07%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:BXE
CDW Holding
0.09
-0.04
-32.00%
SG:5DD
Micro-Mechanics (Holdings)
2.80
1.04
58.64%
SG:558
UMS Integration
2.57
1.42
123.09%
SG:BN2
Valuetronics Holdings
1.00
0.25
34.05%
SG:AWX
AEM Holdings Ltd.
9.63
8.10
530.65%
SG:BDR
Willas-Array Electronics (Holdings) Limited
1.11
0.28
33.73%

CDW Holding Corporate Events

CDW’s LNP-LANFA Drug Delivery Platform Posts Promising Preclinical Results
Jun 29, 2026
CDW Holding’s biotech subsidiary ABio, together with Neoregen Biotech, has reported strong preclinical results in mice for LNP-LANFA, a next-generation lipid nanoparticle platform designed to deliver nucleic acid therapeutics and mRNA vaccin...
CDW Holding Secures Shareholder Backing on Governance, Fees and Share Issue Mandate
May 29, 2026
CDW Holding Limited held its annual general meeting in Singapore on 30 April 2026, where management reviewed the group’s performance for the 2025 financial year and presented its outlook and key developments to shareholders. The meeting conf...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 31, 2026